Virus evolution and strain selection

SCS

Virus evolution and strain selection SCS13

Auditorium 2 - Breakout

Chairs

Kirsty SHORT

ESWI Associate Member, University of Queensland, Australia

Kairat TABYNOV

Kazakh National Agrarian Research University, Kazakhstan

Opening of the session

Kirsty SHORTESWI Associate Member, University of Queensland, Australia

Kairat TABYNOVKazakh National Agrarian Research University, Kazakhstan
1. High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains

Caroline KIKAWAFred Hutch/University of Washington, United States
2. Antigenic mapping of influenza A viruses using deep learning-based prediction of hemagglutination inhibition titers

Bingyi YANGThe University of Hong Kong, Hong Kong SAR China
3. Site specific predictability of amino acid substitutions of seasonal influenza viruses

Annelies DE ROOIJAmsterdam University Medical Center, Netherlands
4. Informal settlements and COVID-19: viral phylodynamic, respiratory microbiome, and public health implications.

Mercedes Soledad NABAES JODARRicardo Gutierrez Children Hospital, Argentina
5. Linking Poultry Supply Chains and Marketing Practices to the Detection of Novel Genotypes Viruses in Bangladeshi Live Bird Markets

To be confirmed
Closing remarks

Kirsty SHORTESWI Associate Member, University of Queensland, Australia

Kairat TABYNOVKazakh National Agrarian Research University, Kazakhstan